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CREB is a pivotal mediator of activity-regulated gene
transcription that underlies memory formation and
allocation. The contribution of a key CREB cofactor,
CREB-regulated transcription coactivator 1 (CRTC1),
has, however, remained elusive. Here we show that
several constitutive kinase pathways and an ac-
tivity-regulated phosphatase, calcineurin, converge
to determine the nucleocytoplasmic shuttling of
CRTC1. This, in turn, triggered an activity-dependent
association of CRTC1 with CREB-dependent re-
gulatory elements found on IEG promoters. Forced
expression of nuclear CRTC1 in hippocampal neu-
rons activated CREB-dependent transcription, and
was sufficient to enhance contextual fear memory.
Surprisingly, during contextual fear conditioning,
we found evidence of nuclear recruitment of endog-
enous CRTC1 only in the basolateral amygdala, and
not in the hippocampus. Consistently, CRTC1 knock-
down in the amygdala, but not in the hippocampus,
significantly attenuated fear memory. Thus, CRTC1
has awide impact on CREB-dependent memory pro-
cesses, but fine-tunes CREB output in a region-spe-
cific manner.
INTRODUCTION
Ca2+/cAMP-responsive element-binding protein (CREB) is a
ubiquitous transcription factor and is activated by phosphoryla-
tion in response to external stimuli (Mayr and Montminy, 2001).
In the nervous system, CREB-dependent gene expression is
essential for long-term memory and plasticity (Bito and Take-
moto-Kimura, 2003; Bourtchuladze et al., 1994; Greer and92 Neuron 84, 92–106, October 1, 2014 ª2014 Elsevier Inc.Greenberg, 2008; Josselyn et al., 2001; Kida et al., 2002; Okuno
et al., 2012; Silva et al., 1998; Suzuki et al., 2011). The expres-
sion of various neuronal immediate early genes (IEGs)—genes
that are primarily induced by neuronal activity—such as c-Fos,
brain-derived neurotrophic factor (BDNF), and activity-regulated
cytoskeleton-associated protein (Arc, also known as Arg3.1) is
predominantly CREB dependent (Bito et al., 1997; Okuno,
2011). Local manipulation of CREB activation has further re-
vealed strong evidence supporting a critical role of CREB in
the formation of memory engrams and allocation of memory
within an active set of neurons (Cowansage et al., 2013; Han
et al., 2007; Zhou et al., 2009). In spite of this significance, our
current understanding about the mechanisms by which the pro-
moters and enhancers of such IEGs are robustly stimulated by
neuronal activity through convergent effects of different sets of
transcription factors and associated coactivators remains
limited. Furthermore, we lack insights on how differential coordi-
nation of transcription may regulate engrams in distinct brain
areas and cooperatively produce a long-term modification of
cognitive performance (Lonze and Ginty, 2002; Nonaka, 2009;
Nonaka et al., 2014).
It has been suggested that IEG expression profiles during
basal and activated states may differ among brain regions, and
such data were considered as functional evidence in support
for an uneven contribution of distinct brain regions during cogni-
tive behavior (Frankland et al., 2004; Okuno, 2011; Tse et al.,
2011). In keeping with this, recent work has indicated differential
CREB phosphorylation profiles and time courses in different
brain regions during reconsolidation and extinction of fear mem-
ory (Cowansage et al., 2013;Mamiya et al., 2009). However, it re-
mains unsolved whether the distinctive neuronal activities in
those brain areas are the sole determinants of such differential
activity-regulated transcription. An alternative hypothesis that
has not been tested so far is the possibility that cellular consoli-
dation of memory-related events might employ distinct CREB
complexes in different brain areas to convert incoming synaptic
inputs to long-term events.
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known as transducer of regulated CREB activity (TORC), has
recently emerged as a unique CREB coactivator that binds to
the basic leucine zipper (bZIP) region of CREB (Conkright
et al., 2003). CRTCs are Ser/Thr-rich proteins (Ser/Thr composi-
tion = 18.3%–21.1%) with multiple phosphorylation and glyco-
sylation sites. Among the known isoforms of CRTC (CRTC1,
2, and 3), CRTC2 has been best explored. In CRTC2, the cova-
lent modification of Ser171, by alternative phosphorylation/glyco-
sylation, determines its subcellular localization: nuclear in the
glycosylated or virgin state, and cytoplasmic in the phosphory-
lated states. CRTC2 plays key roles in gluconeogenesis, insulin
signaling, and cell proliferation in the liver and pancreas (Altare-
jos and Montminy, 2011), whereas CRTC3 contributes to the
development of obesity by attenuating b-adrenergic receptor
signaling in adipose tissue (Song et al., 2010). CRTC1-null
mice also develop obesity as a result of dysregulation of the hy-
pothalamic feeding center (Altarejos et al., 2008). Consistently, in
Caenorhabditis elegans, where only one copy of CRTC gene ex-
ists, CRTC1-dependent transcription via CREB is critical for the
control of energy homeostasis and longevity (Mair et al., 2011).
Interestingly, CRTC1, an isoform that is most abundantly ex-
pressed in the central nervous system (Watts et al., 2011), trans-
locates to the nucleus upon receipt of dendritic synaptic inputs
(Ch’ng et al., 2012). CRTC1 has been implicated in regulation
of the dendrite arborization of developing cortical neurons (Fin-
sterwald et al., 2010; Li et al., 2009), in the control of neuronal
survival after ischemia (Sasaki et al., 2011), and regulation of
circadian clock (Jagannath et al., 2013; Sakamoto et al., 2013).
Despite the critical importance of nuclear CREB-regulated
transcription in cognition, the mechanisms underlying the nucle-
ocytoplasmic shuttling of CRTC1, and CRTC1’s impact onmem-
ory-related processes, have remained elusive.
In order to address these questions, we here identified key
amino acid residues underlying nuclear shuttling of neuronal
CRTC1 via pharmacological and mass spectrometric analyses.
Quantitative understanding of CRTC1’s phosphorylation states
enabled rational designing of a constitutively active mutant
form of CRTC1 (caCRTC1) whose localization was restricted to
the nucleus of neurons both in vitro and in vivo. Chromatin immu-
noprecipitation (ChIP) assays revealed an activity-dependent
association of CRTC1 with CREB-regulated elements on active
IEG promoters. Taking advantage of caCRTC1, we then found
that the nuclear accumulation of CRTC1 was sufficient to mark-
edly stimulate neuronal CREB-dependent gene expression even
in the absence of evoked synaptic activity in vitro or in naivemice
in vivo.Mice virally expressing caCRTC1 in the dorsal hippocam-
pus showed enhancement of long-term contextual fear memory,
which was accompanied by enlargement of dendritic spines.
Surprisingly, during contextual fear conditioning (CFC), nuclear
recruitment of endogenous CRTC1 was detected in the basolat-
eral amygdala (BLA), but not in the hippocampus. In keepingwith
this, CRTC1 knockdown in the amygdala, but not in the hippo-
campus, significantly attenuated fear memory. Taken together,
our study provides evidence for a wide impact of CRTC1 on
nuclear CREB-mediated memory processes, and also indicates
that the phosphorylation states critical for activity-dependent
nuclear translocation of CRTC1 are controlled in a region-spe-cific manner that is distinct from the regulation of CREB phos-
phorylation. Thus, CRTC1 may act as a localized, rather than
global, tunable switching mechanism for specifying CREB
output and activity-dependent transcription, contributing to opti-
mizing the formation and allocation of memory across brain
regions.
RESULTS
Nuclear Shuttling of CRTC1 Is Regulated by
Counteraction of Constitutive Kinase Pathways and
Calcineurin-Dependent Dephosphorylation on Two Key
Serine Residues, Ser151 and Ser245
CRTC1 is a Ser/Thr-rich protein (Ser/Thr content = 21.1%).
To enable high coverage identification for critical phosphory-
lated residues, we performed mass spectrometric analysis of
CRTC1 immunoprecipitated from cultured cortical neurons,
and identified 11 Ser or Thr phosphorylation sites (Figure 1A).
To investigate activity-dependent regulation of these candidate
phosphorylation sites, we established a translocation assay in
primary cultures of mouse hippocampal neurons. The neurons
were initially silenced with 1 mM tetrodotoxin (TTX) in order to
restrict CRTC1 in the cytoplasm and then synaptically activated
by washing out TTX and adding a BIC/4AP cocktail (30 mM
bicuculline, 100 mM 4-aminopyridine, 100 mM glycine, and
1 mM strychnine) to induce nuclear translocation of CRTC1 (Fig-
ure 1B). The neurons were fixed after various incubation times,
and CRTC1 immunoreactivity (IR) was measured in the cyto-
plasm and in the nucleus (Figures 1C and 1D). The activity-
dependent nuclear translocation of CRTC1 was rapid, achieving
a peak and plateau within 2 min after stimulus onset (Figure 1C).
Once the culture medium was returned to the TTX-containing
solution, CRTC1 was exported from the nucleus within 30 min
(Figure 1D). The distribution and redistribution of CRTC1 may
thus serve as a dynamic trace that integrates the incoming syn-
aptic activity of the immediate past.
Diverse kinase and phosphatase pathways have previously
been implicated in regulation of the nucleocytoplasmic shuttling
of CRTC1–3 (Koo et al., 2005; Screaton et al., 2004). We there-
fore examined the kinases that controlled the phosphorylation
states of neuronal CRTC1. Phenformin, a potent activator of
many kinases including AMP-activated protein kinase (AMPK),
prevented the occurrence of both the activity-dependent nuclear
translocation of CRTC1 (Figure S1A available online) and BIC/
4AP-induced CRE-dependent transcription activity (Figure 1E).
Conversely, compound C, an inhibitor of AMPK and salt-induc-
ible kinase 2 (SIK2), promoted the nuclear translocation of
CRTC1 in the presence of spontaneous activity (Figure S1B),
as well as increased the extent of synaptically induced CRE-
dependent promoter activity (Figure 1F). Consistent with these
results, additional experiments showed that kinases that have
been suggested to function upstream of SIK2, including protein
kinase A (PKA) (Figure S1C) as well as a Ca2+/calmodulin-depen-
dent kinase kinase (CaMKK)-CaMKI/IV cascade (Figure S1D),
contributed to the regulation of the nuclear translocation of
CRTC1. Furthermore, overexpression of constitutively active or
dominant-negative forms of microtubule affinity-regulating ki-
nase 2 (MARK2) shifted CRTC1 localization to the cytoplasmNeuron 84, 92–106, October 1, 2014 ª2014 Elsevier Inc. 93
(legend on next page)
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Region-Specific Activation of CRTC1-CREB in Memoryor nucleus, respectively (Figure 1G), implicatingMARK2 as an in-
dependent upstream regulator of neuronal CRTC1. In contrast,
we found that a cocktail consisting of inhibitors of a Ca2+/
calmodulin-dependent protein phosphatase calcineurin (CsA/
FK, cyclosporin A and FK506) attenuated the activity-dependent
nuclear translocation of CRTC1 in a concentration-dependent
manner (Figure 1H), while also inhibiting activity-induced CRE-
dependent promoter activity (Figure 1F).
Together, these findings indicated that in synaptically con-
nected hippocampal neurons, the basal constitutive phos-
phorylation states of CRTC1 were largely under the control of
SIK2/AMPK and MARK2. In combination, these constitutive ki-
nases gated the onset of CRTC1 nuclear translocation, which
was then turned on by an activity-dependent calcineurin-medi-
ated dephosphorylation to facilitate CRE-dependent gene
expression.
We next turned to cultured cortical neurons to determine the
key phosphorylation sites underlying CRTC1’s nuclear shuttling.
We found marked changes in the electrophoretic mobility of
CRTC1 associated with its phosphorylation or dephosphoryla-
tion. The abundance of the lowest-mobility (upper) bands were
increased on exposure of neurons to phenformin or to CsA/FK,
whereas synaptic stimulation of neurons or in vitro treatment
of cell lysates with calf intestinal phosphatase (CIP) increased
the intensity of the highest-mobility (lower) band (Figure 2A).
Alanine-scanning mutagenesis based on the mass spectrometry
data (Figure 1A) revealed that S151A and S245A were mutations
that attenuated the phosphorylation-related mobility shift of
FLAG epitope-tagged CRTC1 (Figures 2B, S2A, and S2B).
Consistent with this, increased synaptic activity triggered
dephosphorylation of these Ser residues in neurons (Figures
S2C and S2D). Interestingly, the combined double mutant
(S151A/S245A) lost any activity-dependent mobility shift (‘‘ca’’
in Figure 2C). These results suggest that Ser151 and Ser245 might
regulate the surface charges and conformation of CRTC1. This
was consistent with a prior report of Ser151 phosphorylation by
SIK2/AMPK (Sasaki et al., 2011), but further highlighted the crit-
ical importance of Ser245 phosphorylation, likely by MARK2, in
cytoplasmic retention of CRTC1 in neurons. Taken together,Figure 1. Kinetics and Signaling Mechanisms of Activity-Dependent N
(A) Domain organization of CRTC1 showing the positions of 11 Ser and Thr residu
cortical neurons treated with TTX and CsA/FK. CBD, CREB-binding coiled-coil
nuclear export signal. The amino acid sequences surrounding each of these 11 S
(B) Cultured hippocampal neurons at 7–11 days in vitro (div) treated with TTX or
(C) Hippocampal neurons were silenced with TTX (blue line) and stimulated with B
units) in the nucleus and cytoplasm (top) and the nuclear/cytoplasmic ratio were
(D) Nuclear/cytoplasmic ratio of CRTC1-IR in hippocampal neurons treated with B
means ± SD.
(E) Luciferase reporter assay for hippocampal neurons transfected with CRE-repo
of phenformin (2 mM) for 4 hr. ***p < 0.001.
(F) CRE-luciferase reporter assay as in (E) treated with TTX or BIC/4AP in the pres
4 hr. Note that compound C alone did not evoke CRE activity, but significantly e
(G) MARK2 is responsible for CRTC1 cytosolic retention. Hippocampal neuron
dominant-negative (dn, T208A/S212A) forms of MARK2 and treated with BIC/4A
(H) Calcineurin is responsible for nuclear translocation of CRTC1. Hippocampal n
various concentrations of CsA and FK506. The nuclear/cytoplasmic ratio of CRT
ulated with BIC/4AP in the absence or presence of 5 mM CsA and 6.4 nM FK50
inhibition are 27 nM and 0.23 nM, respectively. Scale bars, 10 mm. See also Figuthe basal phosphorylation by a constitutive kinase, MARK2,
and by SIK/AMPK, appeared to critically regulate the calci-
neurin-triggered nucleocytoplasmic CRTC1 shuttling.
Forced Nuclear Translocation of CRTC1 Is Sufficient to
Trigger CRE-Dependent Gene Expression
We next examined the functional relevance of these two phos-
phorylation/dephosphorylation sites, Ser151 and Ser245, on
CREB-dependent transcription. The CRTC1 double mutant
(S151A/S245A or caCRTC1) localized almost exclusively to the
nucleus even in the presence of TTX (Figure 3A), although muta-
tion of either site alone was not sufficient to induce such a de-
gree of nuclear translocation (Figure S3A; data not shown). A
sizable portion of the CRTC1 mutant (S151A/S245A) remained
in the nucleus when stimulated in the presence of CsA/FK, indi-
cating that dual-alanine mutation of Ser151 and Ser245 conferred
resistance to calcineurin inhibitors (Figure 3B). A constitutively
cytosolic mutant (mutCN) was generated by introducing muta-
tions in two consensus calcineurin-binding motifs (PxIxIT) of
CRTC1 (Screaton et al., 2004) (Figure 3A). The activities of
both of these mutant proteins in neurons were quantified by
CRE-reporter assays (Figure 3C). First, knockdown of CRTC1
with two independent short-hairpin RNAs (shRNAs) (shCRTC1-
#1 and shCRTC1-#2) showed that CRTC1 is critical for ac-
tivity-regulated CRE-dependent transcription (Figure 3C).
Expression of an shRNA-resistant form of wild-type CRTC1
(WT-CRTC1res) restored the transcription activity in a concen-
tration-dependent manner (Figures S3C–S3E). However,
expression of S151A/S245A (caCRTC1res) in this context
conferred a high level of CRE-dependent transcription even in
CRTC1-depleted neurons exposed to TTX, and this effect was
increased further in the presence of BIC/4AP (Figure 3C). The
latter effect of BIC/4AP was blocked by CsA/FK, implying an
additional calcineurin-sensitive mechanism to further facilitate
CRE-dependent transcription. In contrast, CRTC1 (mutCNres)
did not evoke transcriptional activity in CRTC1-depleted neu-
rons exposed to either TTX or BIC/4AP (Figure 3C). Together,
in contrast to previous studies emphasizing the role of Ser151,
our results revealed a critical role for both Ser151 and Ser245.uclear Shuttling of CRTC1
es (red arrows) found by mass spectrometric analysis to be phosphorylated in
domain; TAD, transactivation domain; NLS, nuclear localization signal; NES,
er or Thr residues are shown on the right.
BIC/4AP (1 hr) were stained with an anti-CRTC1 antibody.
IC/4AP (red line) for the indicated time. The intensity of CRTC1-IR (a.u., arbitrary
quantified (bottom). Data are means ± SD.
IC/4AP (5 min) then transferred to TTX medium for the indicated time. Data are
rter plasmid and treated with either TTX or BIC/4AP in the absence or presence
ence or absence of compound C (CompC, 5 mM) and CsA/FK as indicated for
nhanced BIC/4AP-induced CRE activity. *p < 0.05.
s transfected with expression vectors for constitutively active (ca, T208E) or
P (2 hr) or TTX, respectively, were stained with anti-CRTC1 antibody.
eurons were treated with TTX or BIC/4AP (1 hr) in the absence or presence of
C1-IR was determined as means ± SD. Representative images for cells stim-
6 are shown in the upper panels. Reported IC50 for CsA and FK506 for CaN
re S1.
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Figure 2. Identification of Two Critical Ser Residues of CRTC1 that
Are Dephosphorylated in an Activity-Dependent Manner
(A) Immunoblot analysis of endogenous CRTC1 in rat-cultured cortical neu-
rons incubated in the absence or presence of 2 mM phenformin (Phen) or 5 mM
CsA and 6.4 nM FK506 (CsA/FK) for the indicated time (left). Lysates of neu-
rons treated with TTX or BIC/4AP (30 min) were also treated (or not) with CIP
before immunoblot analysis (right).
(B) Immunoblot analysis of the FLAG-tagged wild-type (WT) and Ser-to-Ala
mutants of CRTC1. Cortical neurons transfected with FLAG-CRTC1 WT and
mutantswere either treatedwith TTX (1.5 hr) or BIC/4AP (30min) at 6 div. Of the
11 Ser/Thr residues (Figure 1A), seven serine residues were further analyzed
based on the positional information and the phosphorylation consensus- and
14-3-3 binding consensus-motif databases (PhosphoMotif Finder, HPRD).
Red arrowheads indicate two Ser-to-Ala mutants that show distinct mobility
shift both in TTX and BIC/4AP conditions compared to WT.
(C) Immunoblot analysis of WT or mutant (ca, S151A/S245A) FLAG-CRTC1 in
cortical neurons treated with TTX or BIC/4AP (30 min). The mobility shift
caused by activity-induced dephosphorylation was almost completely abol-
ished when Ser151 and Ser245 were both mutated to Ala. CIP treatment of the
TTX sample resulted in further downward mobility shift, indicating the pres-
ence of other basal phosphorylation site(s). See also Figure S2.
Neuron
Region-Specific Activation of CRTC1-CREB in MemoryGiven the ability of S151A/S245A mutant of CRTC1 to confer
CRE-dependent promoter activity in neurons even in the pres-
ence of TTX, we hereafter refer to this mutant as caCRTC1.96 Neuron 84, 92–106, October 1, 2014 ª2014 Elsevier Inc.Expression of caCRTC1 did not increase the phosphorylation
of CREB at Ser133 in neurons exposed to either TTX or BIC/4AP
(data not shown), suggesting that the nuclear accumulation of
CRTC1 in the absence of CREB phosphorylation is sufficient to
induce CRE-dependent transcription. To examine this notion
further in an acute system, we constructed caCRTC1-ERT2 by
fusing caCRTC1 to a mutant form of the estrogen receptor (ER)
that is receptive exclusively to a synthetic ligand of ER (Fig-
ure 3D). caCRTC1-ERT2 successfully translocated from cyto-
plasm to nucleus by 4-hydroxytamoxifen (4-OHT) (Figure 3E).
Exposure of the transfected cells to 4-OHT in TTX-containing
medium for 4 hr resulted in amarked increase in CRE-dependent
transcription in neurons (Figure 3F). This activity was further
increased when BIC/4AP was applied with 4-OHT (Figure S3F),
suggesting that there is a combinatorial regulation of nuclear
CRTC1 and other CRTC1-independent CREB regulatory com-
ponents downstream of synaptic activity (see also Figure 3C).
Notably, the 4-OHT-induced acute caCRTC1-ERT2 nuclear
accumulation was not accompanied by detectable increase in
the level of phosphorylated CREB (Figure 3G). We further found
that c-Fos is induced in this condition in the absence of synaptic
activity (Figure S3G). Together, these results supported the
notion that the nuclear translocation of CRTC1 was sufficient
to induce CRE-dependent transcription in neurons, and also
that nuclear CRTC1 might synergize with other synaptic activ-
ity-driven CREB signaling cascades to facilitate CRE-dependent
transcription.
CRTC1 Complexes to the IEG Promoter Regions in an
Activity-Dependent Manner and Mediates Activity-
Dependent IEG Transcription in Neurons
To determine the role of nuclear CRTC1 in neuronal CREB-
dependent gene expression, we next tested whether CRTC1
directly bound IEG promoters. We prepared cortical neurons in
which Myc-tagged CRTC1 was expressed to a minimal level,
such that no additional increase in transcription activity was
detectable in sensitive reporter assays (Figure S4A). Quantitative
ChIP assays using an anti-Myc antibody revealed that CRTC1
was complexed in an activity-dependent manner with the
promoters of Arc, c-fos, and BDNF, and rather constitutively
with the zif-268 promoter (Figure 4A). ChIP assays using anti-
CRTC1 antibodies further confirmed the binding of endogenous
CRTC1 to CRE sites of IEG promoters in high K+-treated cortical
neurons (Figure S4B).
To examine if CRTC1 associates with the promoters via CREB,
we coexpressed A-CREB, a specific inhibitor of CREB function
that binds to bZIP domain of CREB with high affinity (Ahn
et al., 1998). Expression of A-CREB completely blocked
CRTC1-dependent transcription activity (Figure 4B; see also Fig-
ure S4G). Together, we conclude that a functional CRTC1-CREB
complex was recruited to the CRE sites in IEG promoters in an
activity-regulated manner.
To examine the target specificity of CRTC1 on CRE sites
among many regulatory elements in the promoter, we took
advantage of the Arc promoter, which contains a single half-
CRE site in the distal enhancer element termed SARE (Kawa-
shima et al., 2009) that is positioned about 7 kb upstream of the
transcription start site of Arc gene (Figure 4C). Knockdown of
Figure 3. Nuclear Localization of CRTC1 Is Necessary and Sufficient for Induction of CRE-Dependent Transcriptional Activity in Neurons
(A) Schematic representation of WT and mutant CRTC1 forms that localize almost exclusively to the nucleus (caCRTC1, S151A/S245A) or in the cytosol (mutCN)
are shown on the upper left. The position of Ser151 and Ser245 are indicated by red arrowheads, and those of the calcineurin-binding motifs mutated in mutCN are
indicated by blue arrows. The subcellular localizations of the HA-tagged CRTC1 mutants are shown in the right.
(B) The percentage of cells showing a predominantly nuclear localization (Nuc/cyto > 1) of the exogenous proteins after incubation under various conditions for
1 hr was also determined. Note that caCRTC1 is localized in the nucleus in TTX, whereas mutCN is cytoplasmic under any conditions. FSK (5 mM)/IBMX (100 mM)
is a protein kinase A activator cocktail.
(C) CRE-luciferase reporter assay for hippocampal neurons cotransfected with a CRE-dependent reporter plasmid, shRNA expression vectors for control
(shNega) or CRTC1 (shCRTC1-#1), and expression vectors for RNAi-resistant forms (res) ofWT ormutant CRTC1. The cells were exposed to TTX or BIC/4APwith
or without CsA/FK for 4 hr. Data include five independent experiments. The height of the filled and open bars at the bottom of the graph represents the levels of
endogenous CRTC1 and exogenous CRTC1res expression levels, respectively, as determined by ICC in Figure S3C. *p < 0.05, **p < 0.01, ***p < 0.001.
(D) Schematic structure of caCRTC1-ERT2. Red arrowheads indicate two Ser residues mutated in caCRTC1.
(E) Hippocampal neurons transfected with Myc-caCRTC1-ERT2 were exposed to ethanol (Vehicle) or 4-OHT for 1 hr, and then subjected to ICC with anti-Myc
antibody. The percentage of cells showing a predominantly nuclear localization of caCRTC1-ERT2 is shown.
(F) CRE-luciferase reporter assay for hippocampal neurons cotransfected with the reporter plasmid and LacZ (Mock) or caCRTC1-ERT2, and treated with either
ethanol (Vehicle) or 4-OHT for 4 hr in TTX-containing medium. ***p < 0.001.
(G) Acute nuclear translocation of caCRTC1- ERT2 did not induce CREB phosphorylation. Hippocampal neurons expressing Myc-caCRTC1-ERT2 were exposed
to BIC/4AP for 5 min, treated with TTX alone, or 4-OHT in TTX-containing medium for the indicated time. Top panels show ICC with antibodies to Myc and to
pCREB (Ser133). Middle graph shows the percentage of the neurons with nuclear localization of caCRTC1-ERT2. The pCREB-IRs in nontransfected and trans-
fected neurons were quantified (bottom). Slight pCREB-IR increase at 5 min after 4-OHT onset might reflect a response to the medium change. There are no
significant differences between transfected and nontransfected neurons at any time points after 4-OHT treatment. n.s., not significant. Scale bars, 10 mm. See
also Figure S3.
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Figure 4. CRTC1 Binds to IEG Promoters and Induces CRE-Dependent Transcription via CREB
(A) ChIP assay for CRTC1 fromMyc-CRTC1-transfected cortical neurons treated with TTX or BIC/4AP. ChIP eluates were subjected to qPCRwith primers for the
SARE of the Arc promoter, c-fos promoter (proximal), BDNF promoter (pIV), zif268 promoter, or for the unrelated region 7 kb upstream of SARE (Nega) (left). The
ratio of the recovery obtained with anti-Myc to that obtained with control IgG is shown as fold enrichment (right). Control ChIP assays performed with un-
transfected neurons did not yield substantial recovery with anti-Myc antibody (data not shown). Data are from six independent experiments. *p < 0.05.
(B) CRE-reporter assay of neurons transfected withWT-CRTC1 and A-CREB. Note that the transcription activity in this assay is dependent on CRTC1 as shown in
Figure 3C, and this component was totally blocked by the expression of A-CREB.
(C) Schematic representations of the mouse Arc promoter and corresponding wild-type (7 kb) and mutant (mCRE) promoter luciferase reporter constructs. The
CRE is located at 7 kb in the SARE region (yellow box).
(D) Luciferase reporter assay of the Arc promoter (7 kb). Rat cortical neurons transfected with the Arc promoter-reporter construct, an shRNA expression vector
for control (shNega) or CRTC1 (shCRTC1-#2), and an expression vector for CRTC1res were exposed to TTX or to BIC/4AP for 4 hr. **p < 0.01, ***p < 0.001.
(E) Luciferase reporter assay performed as in (D) transfected with an expression vector for caCRTC1 or control GFP. **p < 0.01, ***p < 0.001.
(F) Luciferase reporter assay of cortical neurons transfected with SARE-minCMV promoter (top) or the corresponding plasmid withmutations in the CRE, MRE, or
SRE (mCRE, mMRE, and mSRE, respectively) and an expression vector for caCRTC1 or control GFP (bottom). ***p < 0.001. See also Figure S4.
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component of the full-lengthArcpromoter activity, and this effect
was reversed at least in part by expression ofWT-CRTC1res (Fig-
ure 4D). Furthermore, expressionof caCRTC1 increased the tran-
scriptional activity of the promoter in the presence of TTX to a
level similar to that observed in control neurons stimulated with
BIC/4AP (Figure 4E). The combination of caCRTC1 expression
and BIC/4AP treatment induced an additive effect, whereas mu-
tation of the half-CRE site in the Arc promoter abolished the ef-
fects of caCRTC1 both in TTX and in BIC/4AP (Figure 4E). Next,
to test if there is any local interaction, weused theSARE-minCMV
promoter (Figure 4F). This promoter was largely dependent on98 Neuron 84, 92–106, October 1, 2014 ª2014 Elsevier Inc.CRTC1 (data not shown), similar to the results obtained with the
full-length Arc promoter (Figure 4D). Expression of caCRTC1
induced amarked increase in the SARE-minCMVpromoter activ-
ity, and this effect was abolished by mutation of the CRE motif
(mCRE), but was not influenced by mutation of the MRE, MEF2
response element (mMRE), or SRE, the serum response element
(mSRE) (Figure 4F). These results suggested that CRTC1 acts
solely and directly at the half-CRE of SARE without interaction
with MEF2, SRF, or other nonselective factors.
To determine whether these findings with theArc promoter are
applicable to other CREB-dependent IEGs, we performed re-
porter assays with the proximal promoter of the c-fos gene and
Table 1. Quantification of CRTC1 Knockdown Efficiency in Different Experimental Systems
Experiment Target CRTC1
CRTC1 Level (% to shNega)
Reference FigureshCRTC1-#1 shCRTC1-#2
In vitro (WB from HEK cell) exogenous 44.8% ± 3.51% 24.4% ± 6.47% Figure S3B
In vitro (ICC from neuronal culture) endogenous 27.3% ± 7.35% 25.9% ± 4.24% Figures S3C and S3D
In vivo (IHC at amygdala) endogenous 19.8% ± 1.71% 38.3% ± 3.44% Figures 7A, S6A, and S6B
In vivo (IHC at hippocampus) endogenous 23.2% ± 2.50% 38.4% ± 2.81% Figures 7E and S6F
CRTC1 knockdown efficiency was tested in four different experimental systems shown in the figures (reference figures) and quantified. CRTC1 levels
for shCRTC1-#1- and -#2-expressing systems are shown as percentages of those for shNega. In western blotting (WB), the background was defined in
the area of 110–130 kDa (the size of mEGFP-CRTC1) within the lane of the mEGFP-CRTC1 nonexpressing sample. In ICC and IHC, the background
was defined in the area where there are no cells or tissues, respectively, and subtracted.
Please note the shCRTC1-#1 is more effective in suppressing CRTC1 than shCRTC1-#2 in vivo (both in the amygdala and hippocampus) and of equal
potency as shCRTC1-#2 in neuronal cultures, while shCRTC1-#2 appears to be more effective than -#1 in HEK293 cells.
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dependent onCREB for activity (Sassone-Corsi et al., 1988; Tab-
uchi et al., 2000; West et al., 2001). While activity-independent
phosphoglycerate kinase (PGK) promoter activity was not
affected by CRTC1 (Figure S4C), BIC/4AP-induced activities
for c-fos promoter or pIV-BDNF were attenuated by CRTC1
knockdown, and this effect was reversed in a concentration-
dependent manner by expression of WT-CRTC1res (Figures
S4D and S4E; see also Table 1 and Figure S3D). These c-fos
and pIV-BDNF promoter activities were markedly increased by
expression of caCRTC1 even in the TTX condition, but the
caCRTC1 that lacks the N-terminal CREB-binding domain (ca-
DCBD) had no effect (Figure S4F; data not shown). Furthermore,
all of the caCRTC1 effects were completely blocked by coex-
pression of A-CREB (Figure S4G).
Coimmunoprecipitation experiments in transfected cells re-
vealed that CRTC1 is capable of binding the S133A mutant of
CREB (Figure S4H). In addition, caCRTC1 was coimmunopreci-
pitated with an antibody to CBP from lysates of cortical neurons
silenced with TTX when CREB phosphorylation is minimized
(Figure S4I). These results suggested that caCRTC1 might help
recruit CBP to CRE sites when it is bound to the Ser133 unphos-
phorylated form of CREB in neurons maintained in the TTX con-
dition. In keeping with these findings, our mass spectrometric
analysis identified RNA helicase A as an interaction partner of
CRTC1 (data not shown), which was previously shown to
mediate the association of CBPwith the RNA polymerase II com-
plex (Nakajima et al., 1997). Together, these results suggested
that following nuclear accumulation of caCRTC1 and its binding
to CREB, CBP and likely other factors such as TAFII130 or TAF4
might be recruited (Conkright et al., 2003; Jeong et al., 2012;
Ravnskjaer et al., 2007), thereby perhaps even bypassing the
need for activity-dependent CREB phosphorylation for CREB/
CBP-mediated gene expression.
Dynamics of Nuclear Localization of CRTC1 Play a
Critical Role in Controlling Long-Term Memory
Formation
We next examined whether nuclear CRTC1 upregulates the
expression of endogenous IEGs in neurons. Immunocytochem-
istry (ICC) of cultured neurons transfected with caCRTC1 re-
vealed that caCRTC1 induced the expression of both Arc andc-Fos in the presence of TTX to an extent similar to that induced
by synaptic activity (Figures S5A and S5B). To ascertain these
findings in vivo, we constructed adeno-associated viruses
(AAVs) encoding GFP plus caCRTC1 (AAV-caCRTC1) or GFP
alone (AAV-GFP) and injected them into the CA regions of the
mouse hippocampi (Figure 5A). One week after the injection,
caCRTC1 expression was observed in CA1 pyramidal neurons
(Figure 5B). Consistent with our results in cultured neurons, the
expression of Arc, c-Fos, and BDNF increased in the infected
CA portions of the hippocampus that were injected with AAV-
caCRTC1, while no change was detected when injected with
AAV-GFP (Figures 5C–5E). We found that IEG expression in vivo
was also increased in some noninfected neurons, though much
less consistently and to a lower extent (Figures 5C–5E, right
panels; Figures S5C–S5E). This could reflect either increased
excitability of caCRTC1-expressing neurons that spread through
the hippocampal network, or possibly an effect of released
BDNF toward neighboring neurons, as suggested by increased
BDNF-IR around some, but not all, infected neurons (e.g., Fig-
ures 5E and S5E). Collectively, we conclude that, under our
experimental conditions, forced nuclear localization of CRTC1
in hippocampal CA neurons induces significant upregulation of
neuronal IEG products such as Arc, c-fos, and BDNF throughout
the infected brain areas in vivo.
Next, we investigated the consequences of caCRTC1 expres-
sion in vivo. Previous observations in cultured hippocampal
slices implicated CRTC1 activity in the regulation of dendritic
morphology (Li et al., 2009). We used a two-vector lentivirus
system to confer sparse expression of caCRTC1 in hippocam-
pal CA1 neurons (Hioki et al., 2009) for morphological analyses.
We found that caCRTC1 expression induced Arc and c-Fos
expression as early as 1 week after infection. We then acquired
stacks of images of dendritic spines present on thin secondary
dendrites of CA1 pyramidal cells in the stratum radiatum and
performed 3D reconstruction to compare various spine param-
eters. Expression of caCRTC1 had no detectable effect on
spine density (Figures S5F and S5G). In contrast, caCRTC1
expression induced a significant enlargement of spine heads
(Figures S5F and S5G). The nuclear accumulation of CRTC1 in
hippocampus thus appeared to induce a generalized spread
of morphological plasticity of dendritic spines without altering
spine density. The ability of caCRTC1 to upregulate theNeuron 84, 92–106, October 1, 2014 ª2014 Elsevier Inc. 99
Figure 5. Expression of caCRTC1 in Hippocampal CA Regions In Vivo Induces IEG Expressions and Enhances Long-Term Memory
Formation
(A) Hippocampal sections from amouse injected with AAV-GFP were counterstained with Hoechst 33342 and monitored for GFP fluorescence. Scale bar, 1 mm.
(B) IHC of the mouse hippocampus infected with AAV-caCRTC1 as in (A) using an anti-CRTC1 antibody with Hoechst 33342 counterstaining. caCRTC1 and GFP
are coexpressed in CA1 pyramidal neurons of the mice injected with AAV-caCRTC1. Scale bar, 100 mm.
(C and D) IHC of Arc (C) and c-Fos (D) in the AAV-GFP- or AAV-caCRTC1-infected CA1 region of the hippocampus at 1 week post infection. White dotted lines
indicate pyramidal cell layers (left). Quantifications of the IR intensity in the infected (GFP positive) and noninfected (GFP negative) pyramidal cell soma are
represented as means ± SEM (right graphs). *p < 0.05, ***p < 0.001.
(E) IHC of BDNF in the AAV-GFP- or AAV-caCRTC1-infected CA3 region of the hippocampus at 4 weeks post infection. Perisomatic BDNF-IR intensity was
quantified. ***p < 0.001. Scale bars in (C)–(E), 100 mm.
(F) Contextual fear conditioning test (0.2 mA) of mice injected with AAV-GFP or -caCRTC1 (n = 16 each) bilaterally in the hippocampus at 1 week post injection.
Two-way ANOVA, task 3 virus interaction, F(1,30) = 4.64, p < 0.05; post hoc t test, *p < 0.05.
(G) 2D plot of fear memory performance and caCRTC1 expression level (CRTC1-IR in CA region) for mice (n = 16) injected with AAV-caCRTC1. Each data point
represents one animal, and the bar ends represent the values for caCRTC1 expression level in each hemisphere. Gray shading indicates the area for mean ± SEM
of the performance and CRTC1-IR in the AAV-GFP group. Most data points were aligned in the upper-right and lower-left quadrants (dotted lines are medians of
CRTC1-IR and freezing score), suggesting that the caCRTC1 expression level correlates with the memory (chi-square test, df = 1, p < 0.05). Behavioral and
histological analyses were carried out by an experimenter blinded to the virus type. See also Figure S5.
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Figure 6. Brain-Region Specific Sensitivity
of Nuclear Translocation of CRTC1 in
Response to US-CS-Pairing Stimuli
(A) IHC using anti-CRTC1 antibody of BLA tissues
from mice either in the home cage (Naive), imme-
diate shock (US+/CS) group, conditioned stim-
ulus (CS) alone (US/CS+) group, or CS paired
with foot shock (US+/CS+) group (top). Quantifi-
cation of cells with nuclear CRTC1 signals out of
NeuN-positive neurons (bottom).
(B) IHC using anti-CRTC1 antibody of hippocam-
pal CA1 tissue from mice with the same sets of
conditions as in (A) (top). Quantification of cells
with nuclear CRTC1-positive signals (bottom). For
both (A) and (B), images were analyzed by an
experimenter who was blinded to the CS/US
condition.
(C) IHC using an anti-CRTC1 antibody with
Hoechst 33342 counterstaining of hippocampus
CA1 tissues from mice either in the home cage
(Naive) or 90 min after receiving electroconvulsive
shocks (ECS) (50 mA, 100 Hz, 2 ms duration 3 3
times with 10 s intervals). Scale bars, 50 mm.
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impact of caCRTC1 expression on a hippocampus-dependent
behavior, the CFC test. To maximize the infection efficiency,
we switched to AAVs and bilaterally injected AAV-GFP or
-caCRTC1 into mouse hippocampal CA regions. The AAV-
derived expression increased gradually during the initial 4 weeks
after injection and reached a plateau thereafter. To minimize any
cumulative aberration in hippocampal circuit dynamics induced
by upregulation of IEGs, we performed the test in 1 week post
injection. The long-term contextual fear memory was signifi-
cantly enhanced in mice injected with AAV-caCRTC1 (Fig-
ure 5F). After the test, the extent of caCRTC1 expression was
quantified by immunohistochemistry (IHC) (Figure 5B). A chi-
square test suggested that animals with a higher or lower
expression of CRTC1 tended to show a higher or lower freezing
score, respectively, in reference to the medians of the respec-
tive parameters (df = 1, p < 0.05) (Figure 5G).
CRTC1 Plays a Critical Region-Specific Role in the BLA
during Fear Memory Formation
To test whether endogenous CRTC1 is involved in learning and
memory, we first monitored CRTC1’s localization in the BLA neu-
rons during CFC. While CRTC1 remained largely cytoplasmic in
animals in the home cage, pairing the context (conditioned stim-
ulus [CS]) with the electric foot shock (unconditioned stimulus
[US]) triggered a nuclear accumulation of CRTC1 in some popu-
lations of BLA neurons (Figure 6A). In contrast, however, the CS-
US pairing did not induce nuclear translocation of CRTC1 inNeuron 84, 92–106the hippocampus (Figure 6B). A much
stronger stimulus, such as an electrocon-
vulsive shock (ECS), triggered nuclear
accumulation of CRTC1 in a subset of
hippocampal neurons (Figure 6C), sug-
gesting that the gating mechanism to
prevent nuclear translocation might bemore preponderant in the hippocampus under physiological
conditions.
To ascertain the relevance of this region-specific transloca-
tion, we set out to examine the requirements of CRTC1 in these
areas. We bilaterally injected AAV vectors for two CRTC1 knock-
down constructs and a control AAV-shNega into the BLA (Ta-
ble 1). After 4 weeks, when CRTC1-IR was greatly weakened
by knockdown (Figures 7A, S6A, and S6B; Table 1), both cued
and contextual fear conditioning test performances were signif-
icantly worsened in the AAV-shCRTC1-#1-injected mice (Fig-
ure 7B), in keeping with its potency to suppress the task-related
induction of both c-Fos and Arc (Figures 7C, 7D, S6C, and S6D).
The fear memory defects did not reach statistical significance in
the AAV-shCRTC1-#2 group (Figure 7B), as a subset of CRTC1-
regulated genes such as Arcwere not fully inhibited owing to the
lower in vivo knockdown potency of shCRTC1-#2 (Figure S6D;
Table 1). Forced expression of caCRTC1 in BLA did not enhance
long-term fear memory formation (Figure S6E), suggesting that
CRTC1 signaling is critical, but easily saturates in the amygdala
in accordance with enriched expression of CRTC1 in the amyg-
dala (Watts et al., 2011).
In the hippocampus, shCRTC1 virus produced a significant
reduction in CRTC1 as well (Figures 7E and S6F; Table 1). How-
ever, CRTC1 knockdown had little effect on contextual fear
memory under an experimental condition in which hippocampal
caCRTC1 expression promoted long-term memory (Figure 7F).
This lack of sensitivity to hippocampal CRTC1 knockdown was
not altered by a change in foot shock strength (Figure S6G)., October 1, 2014 ª2014 Elsevier Inc. 101
Figure 7. Differential Contribution of CRTC1 in Long-Term Fear Memory Formation between Amygdala and Hippocampus
(A) IHC using an anti-CRTC1 antibody of the mouse injected in BLA with AAV-shNega, -shCRTC1-#1, and -shCRTC1-#2 at 4 weeks post injection. GFP is
expressed from one of the cassettes of AAV-shRNA vectors. We observed no significant gross neuronal death in AAV-injected areas, as examined with Hoechst
33342 counterstaining (data not shown). Scale bar, 500 mm. White lines in the CRTC1-IR images are the lines used for quantification in Figure S6A.
(B) Cued and contextual fear conditioning test of mice injected with AAV-shNega, -shCRTC1-#1, or -shCRTC1-#2 bilaterally in the BLA at 4 weeks post injection.
One-way ANOVAwith post hoc Tukey-Kramer test; cued test (tone), ANOVAp = 0.010, **p < 0.01 for shNega versus sh#1; contextual test, ANOVA p = 0.037, **p <
0.05 for shNega versus sh#1 (shNega n = 14, sh#1 n = 15, sh#2 n = 20); note that shCRTC1-#2 is less efficient in knockdown in vivo (Table 1).
(C) Quantification of the percentage of c-Fos-positive cells (in the central area of the BLA) after fear conditioning test. Representative IHC images are shown in
Figure S6C.
(D) Same as (C) but for Arc (IHC images shown in Figure S6D).
(E) IHC using an anti-CRTC1 antibody of the mouse hippocampus infected with AAV-shNega, -shCRTC1-#1, and -shCRTC1-#2 at 4 weeks post injection. Scale
bar, 200 mm.
(F) Contextual fear conditioning test (0.2 mA) of mice injected with AAV-shNega, -shCRTC1-#1, or -shCRTC1-#2 (shNega n = 11, sh#1 n = 7, sh#2 n = 9) bilaterally
in the hippocampus at 4 weeks post injection. n.s., not significant by one-way ANOVA.
(G) IHC using an anti-c-Fos antibody of the dentate gyrus area of the hippocampus infected with AAV-shNega, -shCRTC1-#1, and -shCRTC1-#2 at 4 weeks post
injection with or without enriched environment. Scale bar, 100 mm. Behavioral and histological analyses were carried out by an experimenter blinded to the virus
type. See also Figure S6.
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ronment-induced expression of c-Fos and Arc (Figure 7G; data
not shown). These results are in keeping with our original obser-
vation that CS-US pairing did not trigger nuclear translocation of
hippocampal CRTC1 (Figure 6B). Taken together, these results
provide evidence that CRTC1 functions in a region-specific
manner, with a much higher contribution in the amygdala, to
fine-tune the CREB output during long-term memory formation.
DISCUSSION
In this study, we combined biochemical, cell biological, pharma-
cological, virus-mediated genetic engineering, and behavioral
approaches to decipher key neuronal regulation mechanisms
of CRTC1 as a CREB coactivator, and revealed an intriguing re-
gion-specific requirement for CRTC1 during long-term fear
memory formation.
The extremely Ser/Thr-rich amino acid composition of CRTC1
has so far hindered comprehensive investigation of its regulatory
phosphorylation mechanisms. Here we took a highly sensitive
mass spectrometric approach to determine the critical residues
responsible for its activity-regulated nuclear translocation.
CRTC1 is multiphosphorylated in the resting state in sharp
contrast to CREB, which is dephosphorylated at a resting state,
constitutively nuclear-localized, and depends on a single critical
phosphorylation of Ser133. Among the many phosphorylation
sites of CRTC1 we identified, two (Ser151 and Ser245) appeared
to critically participate in the activity-dependent dephosphoryla-
tion process and contribute to the nuclear translocation of
CRTC1. The kinetics of the nuclear shuttling regulated by
Ser151 and Ser245 were in keeping with the transport rate of
CRTC1 from the dendrites to the nucleus (Ch’ng et al., 2012).
Previous studies in overexpressed cells have suggested that
both phosphorylation of CRTC1’s C terminus and dephosphory-
lation of more N-terminal and central residues might regulate
its nuclear transport. Here we unequivocally determined two
classes of kinases, one constitutive (MARK2) and the other
metabolically regulated (SIK2/AMPK), for cytoplasmic retention,
and demonstrated that activity-regulated calcineurin unlocked
the gating.
Furthermore, a direct transcriptional impact of nuclear CRTC1
transport on CRE/CREB-dependent gene expression was
shown both in vitro and in vivo. Although a recent report sug-
gested that in nonneuronal cells CRTC1 might augment CREB
Ser133 phosphorylation via PRMT5 (Tsai et al., 2013), we were
unable to detect such a change in CREB states in neurons
(e.g., Figure 3G). The precise mechanism by which CRTC1
may facilitate CREB’s transcriptional activity while bypassing
CREB phosphorylation, and how CRTC1 cooperates with other
activity-regulated mechanisms, should be the focus of future
study. One possible scenario we currently favor is that formation
of CRTC1-CREB complex facilitates recruitment of CBP and
transcription initiation complex proteins such as TAFII130, as
has been suggested in nonneuronal cells (Conkright et al.,
2003; Heinrich et al., 2013).
Finally, CREB has been widely implicated in long-term mem-
ory formation via regulation of neuronal excitability in various
areas of the brain. Here we uncovered that CRTC1 modificationwas controlled through a complex web of both activity-regulated
and unregulated pathways. Opposing CRTC1 regulation by ki-
nases and calcineurin might permit addition of an independent
tunable switch to CREB-dependent gene expression, perhaps
to better regulate memory strength specifically during consoli-
dation (Sekeres et al., 2012). Notwithstanding this interest,
evaluating the impact of endogenous CRTC1 on memory perfor-
mance was previously difficult due to a severe mood dysregula-
tion in CRTC1-null mice (Breuillaud et al., 2012).
Recent evidence suggests that even subtle modulation of
CREB signaling significantly affects an amygdala-dependent
memory (Cowansage et al., 2013). While CREB phosphorylation
is mainly determined via concerted activity of several activity-
dependent kinases (Bito et al., 1996; Deisseroth and Tsien,
2002), CRTC1 may be more susceptible to metabolic states of
neurons and may also decode neuronal activity that is distinct
from those governing CREB phosphorylation per se such as
long-lasting low-frequency synaptic stimulation that strongly
stimulates calcineurin (Fujii et al., 2013). Consistent with this,
we found that nuclear translocation of CRTC1 was triggered by
fear conditioning only in the amygdala. Region-specific interro-
gation using viral vectors and CRTC1-specific reagents further
unveiled that memory consolidation mechanisms downstream
of CRTC1 might be differentially regulated and contribute
more to fear memory formation in the amygdala than in the
hippocampus.
The lack of hippocampal CRTC1 contribution in mice under
our experimental conditions (Figure 7) does not necessarily
rule out a role for hippocampal CRTC1 under circumstances
where CREB-dependent gene expression may become in
much higher demand. Consistent with this idea, augmented hip-
pocampal CRTC1 expression was reported to be beneficial in
rescuing behavioral and gene expression defects in 6-month-
old mice that mimicked pathologies underlying Alzheimer’s dis-
ease, but the same manipulation had little effect in WT mice
(Parra-Damas et al., 2014).
Taken together, our findings shed new light on the combinato-
rial and brain region-specific modulation of molecular cascades
implicated in CRTC1-CREB-dependent gene expression crucial
for formation and allocation of long-term fear memory.
EXPERIMENTAL PROCEDURES
All animal experiments were performed in accordancewith the regulations and
guidelines of the University of Tokyo, the Tokyo University of Agriculture, and
the Japan Neuroscience Society and approved by the institutional review
committee of the University of Tokyo, Graduate School of Medicine and of
the Tokyo University of Agriculture.
Primary Neuron Culture and Transfection
Primary cultures of hippocampal CA neurons from postnatal days 0–1 ICR
mice (SLC) were prepared as previously reported (Nonaka et al., 2006) and
transfected using Lipofectamine 2000. Cortical neuron cultures from E17–18
rats were prepared, transfected using AMAXA Nucleofector electroporation
system (Lonza), and seeded onto poly-D-lysine-coated dishes (Ageta-Ishihara
et al., 2009).
Reporter Assays
Hippocampal neurons were cotransfected with a promoter-of-interest-driven
luc2P plasmid, the PGK promoter-driven Renilla plasmid, and either theNeuron 84, 92–106, October 1, 2014 ª2014 Elsevier Inc. 103
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Region-Specific Activation of CRTC1-CREB in MemoryCRTC1 knockdown plasmid and/or mutant or WT CRTC1 expression plasmid.
Neurons were treated with TTX for 5 hr and stimulated with BIC/4AP for 4 hr,
then lysed. The luciferase activity of firefly normalized with Renilla was calcu-
lated (Kawashima et al., 2009).
Mass Spectrometry
Rat cortical neurons were transfected with FLAG-CRTC1. At 6–8 DIV, the neu-
rons were either treated with TTX or BIC/4AP, and FLAG-CRTC1was immuno-
precipitated from the lysate, digested, and desalted. Mass spectrometry was
conducted on an LTQ Orbitrap XL instrument (Thermo Fisher Scientific, San
Jose). A nanoFrontier HPLC system (Hitachi) was connected to themass spec-
trometer for LC-MS/MS.
ChIP Assay
Neuronal nuclear lysate preparation and ChIP were performed using a ChIP-IT
Express Kit (Active Motif) as reported previously (Kawashima et al., 2009).
In Vivo Virus Injection
Lentivirus and AAVs were produced and purified as described in Kawashima
et al. (2009) and Kawashima et al. (2013), respectively. The viral injection pro-
cedure was essentially as described in Han et al. (2007).
Behavioral Analysis
Fear conditioning tests were performed as previously described (Fukushima
et al., 2008). Briefly, the mice were placed in a training chamber for 148 s,
and a foot shock was applied. On day 2, the mice were placed in the same
chamber for 300 s (contextual test) during which the freezing was measured.
Cued and contextual fear conditioning tests for experiments targeting amyg-
dala were performed as follows; the mice were placed in a conditioning cham-
ber ‘‘A’’ for 120 s, and a tone was applied for 30 s that coterminated with a foot
shock. On day 2, the mice were placed in chamber ‘‘B,’’ and 180 s later the
tone was applied for 180 s (cued test). On day 3, the mice were placed in
the chamber ‘‘A’’ for 300 s (contextual test). All experiments were performed
by experimenters blinded to the virus type.
Coimmunoprecipitation Assay and Western Blotting
Coimmunoprecipitation assay was performed as described previously (Okuno
et al., 2012). HEK293 cells or cortical neurons were lysed in RIPA buffer, and
the lysate was mixed with primary antibody, in which protein G Sepharose
(GE Healthcare, Amersham) was added later. The input and eluates were run
on an acrylamide gel, blotted to PVDF membrane, and detected with an
antibody.
ICC and IHC
ICC and IHC were performed in general procedures. For ICC, the cells were
fixed in 4% paraformaldehyde/PBS for 15 min at RT. For IHC, mice were
deeply anaesthetized and perfused with cold 2% or 4% paraformaldehyde/
PB.
All data are shown as the mean ± SEM unless otherwise indicated in the
figure legend. See Supplemental Information for more detailed procedures.
SUPPLEMENTAL INFORMATION
Supplemental Information includes six figures and Supplemental Experimental
Procedures and can be found with this article online at http://dx.doi.org/10.
1016/j.neuron.2014.08.049.
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